Louise has an interest in bioethics and has over 20 years of experience on Research Ethics Boards, including the Hospital for Sick Children, Veritas IRB Inc., and the CIHR Research Integrity Council.
Louise has an Honours Bachelor of Arts and Science degree, with a business minor. For 10 years, Louise worked in the Canadian pharmaceutical and health care consumer packaged goods industry in management and marketing.
MD, DPhil, FRCPC
Organizations and medical journals from around the world have endorsed the SPIRIT guidelines as part of their clinical trial policies. Dr. Chan has also served as a Special Advisor to the Clinical Trials Unit of the Canadian Institutes of Health Research. He helped coordinate the World Health Organization’s International Clinical Trials Registry Platform in Geneva and chairs its advisory board.
RRT, BA, MA, PhD
Carolyn Ells is an Associate Professor (retired), Faculty of Medicine and Health Sciences, McGill University and Associate Researcher at the Lady Davis Institute for Medical Research. Carolyn is a philosopher with a specialization in bioethics. Carolyn’s service on university and hospital research ethics boards (REBs) fostered her interest in research ethics policy and review processes.
Carolyn has an extensive understanding of research methodologies and challenges, normative texts and their application to ethical research, resolution of challenging research ethics situations, and the realities faced by academic researchers, REBs and their institutions. Carolyn published work on these themes in the British Medical Journal, the Canadian Journal of Sociology, the Journal of Medical Ethics, the International Journal of Feminist Approaches to Bioethics, the Qualitative Report, and various other journals.
Carolyn’s professional service includes co-developing a six-module, online research ethics tutorial targeting REB members and support staff within the Quebec health and social services network; membership on the Panel on Research Ethics (PRE), including six years as Chair; PRE advisory committees on Population and Pubic Health Research, Material Incidental Findings (Chair), Cell Lines, and Course on Research Ethics (CORE) Renewal; Canadian Council on Animal Care (CCAC) Standards Committee; HRSO Technical Committee for CAN/HRSO-200.01–2021 “Ethical Review and Oversight of Human Research”; and a contributor to HRSO Technical Committee for CAN/HRSO-300.01-2022 “Conduct of Human Research”.
BSc (Hons), MSc, PhD
Andrew holds a BSc (Hons), and a MSc and PhD from the University of New Brunswick with a focus in Natural Products Chemistry. Andrew was a recipient of the NSERC Alexander Graham Bell Canada Graduate Scholarship for doctoral studies. Andrew completed a Postdoctoral Fellowship at the University of Calgary investigating antimicrobial drug leads from the human microbiome and was a recipient of the Alberta Children’s Hospital Research Institute Postdoctoral Fellowship.
Andrew is a Technical Committee member of Human Research Standards Organization (HRSO), having contributed to the development of the National Standards of Canada (NSCs) CAN/HRSO-300.01-2022 “Conduct of Human Research” and CAN/HRSO-100.02-2022 “Development of a Training Program for Human Research”.
Professor Isasi’s research is devoted to identifying and analyzing the social, ethical and policy dimensions of novel and disruptive genetic technologies. She has built an international reputation as a scholar with particular expertise in the area of international comparative law and ethics regarding genomics and regenerative medicine.
Professor Isasi holds many leadership roles in major international initiatives. She was recently named the President’s International Fellow of the Chinese Academy of Sciences (CAS). Professor Isasi is Co-Investigator and Ethics/Regulatory/Communications lead for the SouthEast Enrollment Center (SEEC) a consortium member of the NIH’s All of Us Research Program. In addition, she serves as the Ethics/Policy Advisor of the European Commission’s European Human Pluripotent Stem Cell Registry (hPSCREG), is a member of the Ethics Advisory Board of the Vanderbilt-Miami-Meharry Center of Excellence in Precision Medicine and Population Health and the American Society for Human Genetics (ASHG) Task Force on Gene Editing. Finally, Professor Isasi is a member of the Ethics & Policy Committee of the International Society for Stem Cell Research (ISSCR) and is the Chair of the International Stem Cell Forum (ISCF) Ethics Working Party, a consortium of funding agencies for regenerative medicine.
Michal Helbin holds a Master’s Degree in Pharmacy from the Medical University (Poland) and has more than 30 years of pharmaceutical industry experience.
Michal has held numerous positions in government and private companies. Michal worked as an Inspector for the Ministry of Health (Poland), and corporations such as Bristol-Myers Squibb Co., (clinical operations, Central and Eastern Europe; Global Quality Manager, Central and Eastern Europe, Russia and Turkey), and ApoPharma Inc. a division of Apotex Inc. (implementation of quality systems, internal and external audits, government inspections). Michal is currently the Senior Director of Quality Assurance and Training at NoNO Inc.
Michal’s primary interest is research ethics (clinical research), the wellbeing of research participants, and data integrity.
Currently, Alex is the Manager of Clinical Research Support Systems at the University Health Network (UHN), Canada’s largest academic research network. He has been involved in the management of compliance, integrity, planning and communication activities both in healthcare and university environments. Alex has also developed and delivered education in research ethics, institutional authorization and clinical research considerations as a facilitator in UHN’s Quality Clinical Investigator Practices (QCIP) training program targeting new Principal Investigators, Clinical Fellows as well as Clinical Research Fellows and clinical research staff engaging in research involving humans.
Alex is appointed as an Academy Scholar to The Institute for Education Research (TIER) at UHN. He has also been appointed to the Canadian Association of Research Ethics Boards (CAREB-ACCER) Circle of Experts and is an REB Operations Expert representative on the Clinical Trials Ontario College of Reviewers. Alex played a leadership role at CAREB-ACCER as President and on the Board of Directors and he currently serves as a member on several committees including the Human Research Standards Organization (HRSO) Technical Steering Committee.
Alex has a Bachelor of Science with a double major in Human Biology and Physiology and a minor in Microbiology from the University of Toronto, a Bachelor of Applied Arts and a Certificate in Economic Analysis from Ryerson University, and has completed the UHN-Rotman Leadership Development Program at the University of Toronto.
PEng, CIH, ROH
Liz is the founder and President of KRMC – Risk Management Consultants Inc., a multidisciplinary firm with expertise in the risk management of hazardous materials and processes. Her expertise is in managing risks resulting from the use of chemicals, biohazards, ionizing radiation and lasers.
Liz spent approximately 25 years in the academic sector working at the University of Toronto and Ryerson University in various health and safety roles.
Throughout her career, Liz has worked across Canada performing risk assessments, audits, program development and managed numerous hazardous materials projects in various sectors including research facilities, biotech and pharmaceutical, commercial, high tech, manufacturing, healthcare, government and public agencies.
RN, BN, CIPP/C
Jacquelyn’s venture into the research world began with clinical trials in 1995 as a clinical trials nurse and evolved into a position in Research Ethics from 2003 to 2013. Jacquelyn was Chair of the Research Ethics Board for the former Atlantic Health Sciences Corporation from 2004-2008. In 2008, New Brunswick’s eight regional health authorities were amalgamated and in 2009, a regional Research Ethics Board for HHN was established.
Jacquelyn played an integral role in the planning and implementation of HHN’s regional REB which was recognized as a leading practice in 2010. She chaired the REB until 2011 and served as its administrator until 2013. Jacquelyn was an elected member of the Board of Director’s for the Canadian Association of Research Ethics Boards from 2008-2013 holding a VP position from 2011-2013.
Jacquelyn is a Certified Information Privacy Professional (CIPP/C) and a facilitator for HHN’s leadership development program. Jacquelyn received her diploma in nursing in 1988 from the Saint John School of Nursing and her Bachelor of Nursing degree from the University of New Brunswick in 2011.
Kim has volunteered with the Clinical Research Association of Canada (CRAC) for the past 18 years. In her various roles, including President, Kim has provided leadership as CRAC went online, helped develop a certification program (CRPC), and continues to recommend quality speakers for the membership on topics of importance in Canadian clinical research. Kim is on the Board of Directors of Brain Injury Canada where she volunteers as secretary.
Kim was named Volunteer of the Year in 2016 from Brain Injury Canada, and in 2018, was awarded the Canada Talks Pharma Excellence in Clinical Research Award.
Kim earned her MSc in toxicology from the Ontario Veterinary College at the University of Guelph. She has presented and co-chaired sessions at DIA, DIA Canada, ACRP and other meetings over the past 15 years.
BScN, MN, PhD
Dr. Moffitt holds an Honorary Professor designation at the University of the Arctic in Tromso, Norway where she is an invited lecturer and researcher. Dr. Moffitt studied in Potchefstroom, South Africa where she completed an International Internship for Health Science Researchers.
For the past fifteen years, Dr. Moffitt’s research focus has been on Indigenous and Women’s Health and Rural and Remote Nursing. She has generated knowledge in breastfeeding, quality of life of older adults, intimate partner violence and the nature of rural and remote nursing in Canada.
Dr. Moffitt is currently a Principal Investigator in the SPOR Evidence Alliance, a CIHR project, and contributes to the Canadian Femicide Observatory for Justice and Accountability. For her research contributions in the NWT, Premier McLeod bestowed her with the prestigious “Wise Woman” award.
Dr. Marie-Laurence Tremblay has been the Research Ethics Manager at Nova Scotia (NS) Health, a provincial healthcare system, since 2020. In her role, Marie-Laurence oversees the operational efficiency and quality of four REB review processes. Grounded in action-oriented team outcomes, Marie-Laurence has provided considerable leadership to several new initiatives aiming to modernize and streamline clinical research, which started with launching electronic informed consent for clinical research within the first four months of her tenure. Since then, Marie-Laurence has utilized the REB review operations as the central connectivity node within a network of institutional regulatory, privacy, contractual, and ethical review/approval pathways for clinical research.
Marie-Laurence has also been instrumental in managing a team of international consultants, local researchers and administrators to realize the first implementation and enablement of a decentralized clinical trial protocol at NS Health. Trained in policy development and implementation, Marie-Laurence has been leading a team to develop a new accredited Human Research Protection Program and is also leading the integration of a new centralized institutional biobank through policy/process.
Marie-Laurence graduated with her PhD in Biochemistry and Molecular Biology from Dalhousie University in 2015. She then pursued a four-year Postdoctoral Fellowship at the Biomedical Translational Imaging Center in Halifax, studying novel non-invasive imaging detection methods for immune cells in gynecological cancer animal models in partnerships with Cubresa Inc. and IMV Inc, a local pharmaceutical company. She was involved in multiple grant review committees and authored 13 peer-reviewed scientific publications. Marie-Laurence sits on the Human Research Standards Organization Technical Committee and the Atlantic Clinical Trial Network REB working group.
For the last 17 years, Sheri has been working in various roles in clinical research specializing in quality assurance, compliance and regulatory affairs. Sheri’s experience spans both the private and public sectors, having held positions at contract research organizations, academic research hospitals and assisting with the qualification of Research Ethics Boards through Clinical Trials Ontario and Toronto Academic Health Science Network.
Sheri is currently the Manager of Research Safety, Ethics, Training & Compliance at the Health Sciences North Research Institute. In this position, Sheri assisted with the development of the ICES North satellite site in Sudbury, Ontario.